Clinical Trial Update: Immunogenicity and Safety of Vaccine Against Tetanus and Diphtheria. [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating immunogenicity and safety of a tetanus and diphtheria vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Tetanus

Drugs mentioned

• Vaccine Against Tetanus and Diphtheria

Snippet

Sponsor: IBSS Biomed S.A. | Conditions: Diphtheria, Tetanus | Phase 3 | Status: UNKNOWN